When Ark Invest (ARK) sold a substantial stake in Palantir (PLTR), it proved too early. PLTR stock continued to rise to an all-time high yesterday. Retail investors will continue to accumulate the software firm after the S&P 500 (IVV) added the company to the index.
In the drug manufacturing sector, Pfizer (PFE) is above $30.00 again. The firm declared a $0.42 a share quarterly dividend, which yields 5.56%. The dividend is payable on Dec. 2 for shareholders of record on November 8, 2024. The firm may face headwinds for its RSV vaccines. U.S. regulators narrowed the targeted age range. In addition, people only need one shot in a lifetime.
Investors seeking a pure play in vaccine stocks may consider Moderna (MRNA) and Novavax (NVAX). However, Roche (RHHBY) is the most appealing. The firm sells diagnostics for infections. In addition, it is working on an obesity drug. The risk is that its pill, CT-996, may have side effects like gastrointestinal issues and increased heart rate.
In the technology sector, Broadcom (AVGO) has the strongest momentum. After a brief post-earnings slump, the stock broke out yesterday to close at a new high of $185.95. In the cybersecurity space, Fortinet (FTNT) broke out to close at above $80. Crowdstrike Holdings (CRWD), which bottomed at $200 in August, continued to rebound. It should close at above $300 this week.
